| Literature DB >> 35001210 |
Sedighe Hosseini Shabanan1, Homa Seyedmirzaei1,2,3, Alona Barnea4, Sara Hanaei1,2,3, Nima Rezaei5,6,7.
Abstract
Retinal degenerative diseases such as retinitis pigmentosa (RP) are of the major causes of vision loss in developed countries. Despite the unclear pathophysiology, treatment methods have been investigated vastly in the past decades. This review article mainly discusses the advances in application of stem cell and progenitor transplantation for retinitis pigmentosa. Stem cell sources such as mesenchymal stem cells, embryonic stem cells, induced pluripotent stem cells, neural stem cells, retinal progenitor cells, and olfactory ensheathing cells are discussed separately in addition to a brief description of two approaches for treatment of early-stage RP, including gene therapy and nutritional therapy.Entities:
Keywords: Cell therapy; Gene therapy; Nutritional therapy; Retinitis pigmentosa; Stem cell transplantation
Mesh:
Year: 2022 PMID: 35001210 DOI: 10.1007/s00441-021-03551-3
Source DB: PubMed Journal: Cell Tissue Res ISSN: 0302-766X Impact factor: 5.249